Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL)
Clinical trial NCT00042341 · COMPLETED
Trial details
- NCT number
- NCT00042341
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.